Pfizer's efficiency at spending on R&D and Capex is set to look much better. Click here to see why PFE stock is a Buy.

John Hancock Tax-Advantaged Dividend Income Fund offers a compelling mix of capital appreciation and a high 7.7% dividend ...

Guess reported disappointing 3Q25 results, with poor North American sales and a second guidance cut. See why GES stock is a ...

NVDY ETF offers high distribution yields by selling short-dated, slightly out-of-the-money calls on NVIDIA. Click here to ...

Despite macroeconomic challenges, JKS shows a bullish reversal pattern, holding the 200-day moving average, making it a stock ...

AMD has good and stable management, which is becoming its core strength as Intel searches for another CEO. Read why I'm ...

Check Point's aggressive share repurchases surpass its FCF, raising concerns about the sustainability of this strategy. Read ...

The SPDR S&P 400 Mid Cap Growth ETF provides low-cost exposure to mid-cap growth companies. Click here to read why I rate ...

Recent product expansions, including GenAI solutions and IRN 2.0, enhance FactSet's market position and growth trajectory.

AXIS Capital has a diversified portfolio, disciplined risk management, and innovation focus. Read why AXS stock is a ...

Dollar General's usage of promotions to sustain business with consumers is impairing gross and EBIT margins. Read why I will ...

Adobe's extensive product variety and quality offers unique marketing solutions. Click here to read why ADBE stock is a Hold.